Saltvae Pharmaceuticals Private Limited, a active private limited company, was established on 16 March 2021 in Noida, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239UP2021PTC143662. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
Its leadership includes Rashi Goswami (Director), Harnand Tyagi (Director), Chander Prakash Goswami (Director). It holds ₹3.63 Cr open charges and ₹7.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-61 Sector-88, Noida, Uttar Pradesh, 201301.
U24239UP2021PTC143662
143662
16 March 2021
₹5.00 M
₹5.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Saltvae Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rashi Goswami | Director | 16 Mar 2021 | Current |
| Harnand Tyagi | Director | 16 Mar 2021 | Current |
| Chander Prakash Goswami | Director | 28 Apr 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Saltvae Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1019.84% increase. The company also saw a substantial improvement in profitability, with a 91.37% increase in profit. The company's net worth dipped by a decrease of 1.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Saltvae Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹36,250,981.00
₹7,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2025 | Others | ₹6.00 M | Open |
| 04 Sep 2025 | Others | ₹1.65 Cr | Open |
| 04 Sep 2025 | Others | ₹1.20 Cr | Open |
| 22 May 2025 | Others | ₹1.75 M | Open |
| 31 Jul 2023 | Others | ₹4.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Saltvae Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Saltvae Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saltvae Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 31 Jul 2023 via Charge ID 100787688 with Others was fully satisfied on 03 Oct 2025. was documented.
The activity A charge with Others amounted to Rs. 6.00 M with Charge ID 101162066 was registered on 04 Sep 2025. was completed.
The activity A charge with Others amounted to Rs. 16.50 M with Charge ID 101162047 was registered on 04 Sep 2025. was completed.
Progress on A charge with Others amounted to Rs. 12.00 M with Charge ID 101162003 was registered on 04 Sep 2025. was documented.
A charge registered on 29 Jul 2022 via Charge ID 100599968 with Canara Bank was fully satisfied on 26 Aug 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.75 M with Charge ID 101132100 was registered on 22 May 2025. was completed.
The CIN of Saltvae Pharmaceuticals Private Limited is U24239UP2021PTC143662.
Saltvae Pharmaceuticals Private Limited is headquartered at C-61 Sector-88, Noida, Uttar Pradesh, 201301.
Saltvae Pharmaceuticals Private Limited was incorporated on 16 March 2021.
The current directors of Saltvae Pharmaceuticals Private Limited are
The primary industry of Saltvae Pharmaceuticals Private Limited is Manufacturing.
Saltvae Pharmaceuticals Private Limited is unlisted.
The authorized capital of Saltvae Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX